Reprogramming of alternative splicing of genes associated with breast cancer
Alternative splicing is a process that modulates gene expression and contributes to protein diversity. However, alterations have been observed that harm alternative splicing and promote the development of oncogenic isoforms in breast cancer. Breast cancer is the most common neoplasm in women and the...
| Autores: | , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2021 |
| País: | México |
| Institución: | UNIVERSIDAD DE SONORA |
| Repositorio: | Epistemus |
| Idioma: | español |
| OAI Identifier: | oai:oai.epistemus.unison.mx:article/186 |
| Acceso en línea: | https://epistemus.unison.mx/index.php/epistemus/article/view/186 |
| Access Level: | acceso abierto |
| Palabra clave: | splicing cáncer mamario oligonucleótidos antisentido breast cancer antisense oligonucleotides |
| Sumario: | Alternative splicing is a process that modulates gene expression and contributes to protein diversity. However, alterations have been observed that harm alternative splicing and promote the development of oncogenic isoforms in breast cancer. Breast cancer is the most common neoplasm in women and the leading cause of death from cancer. This paper analyzes the expression of isoforms involved in tumor progression and the use of antisense oligonucleotides as a treatment for breast cancer. The information reveals that the deregulation of the BirC5 and KLF6 genes is involved in tumor progression and invasion, inhibition of cell death, and metastasis. In addition, antisense oligonucleotide therapies are reported, which re-establish alternative splicing of genes involved in spinal muscle atrophy, pancreatic cancer, colon cancer, and glioblastoma. |
|---|